Vishnu K: The Growing Role of RET-He in Modern Hematology
Vishnu K, Hematopathology Postgraduate at Nitte University, shared a post on LinkedIn:
“RET-He: Precision Anemia Management.
Early detection is the key to effective anemia management. Reticulocyte Hemoglobin Equivalent (RET-He) is emerging as a powerful biomarker that assesses the real-time availability of iron for red blood cell production—often identifying iron deficiency before changes in hemoglobin become apparent.
By enabling earlier diagnosis, monitoring response to iron therapy within days, and supporting anemia management in conditions such as chronic kidney disease, inflammation, pregnancy, and pediatric populations, RET-He is advancing a more precise and personalized approach to patient care.
As laboratory medicine continues to evolve, innovative biomarkers like RET-He are helping clinicians make faster, evidence-based decisions that improve patient outcomes.
Precision diagnostics. Timely intervention. Better patient care.”

Stay updated with Hemostasis Today.
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments